معرفی
Cecilia Costiniuk, MD, MSc, is an Associate Professor at the Department of Medicine, Faculty of Medicine and Health Sciences, McGill University, and a Scientist at the Rosalind and Morris Goodman Cancer Research Centre (RI-MUHC), Glen site. Her research focuses on accelerated chronic lung disease in HIV infection, investigating pulmonary HIV reservoirs, inflammation, and vaccine immunogenicity in HIV-positive populations. She also explores the endocannabinoid system as a therapeutic target for reducing HIV reservoirs and comorbidities.
- Key Research Areas:
- HIV reservoirs in pulmonary tissue
- Chronic lung disease mechanisms
- Vaccine immunogenicity optimization
- Endocannabinoid system modulation
Selected Publications highlight her work on COVID-19 vaccine efficacy in HIV patients, oral cannabinoid trials, and lung microbiome interactions. She collaborates with the COVAXHIV Study Group and CTN PT028 pilot trial team, though no specific awards are listed in the provided data. Her lab operates within the Infectious Diseases and Immunity in Global Health Program at RI-MUHC.
